Doerfler, Phillip A. http://orcid.org/0000-0001-7566-9073
Feng, Ruopeng
Li, Yichao http://orcid.org/0000-0001-5791-096X
Palmer, Lance E. http://orcid.org/0000-0002-2519-8602
Porter, Shaina N.
Bell, Henry W. http://orcid.org/0000-0003-4677-8208
Crossley, Merlin http://orcid.org/0000-0003-2057-3642
Pruett-Miller, Shondra M. http://orcid.org/0000-0002-3793-585X
Cheng, Yong http://orcid.org/0000-0002-9314-0971
Weiss, Mitchell J. http://orcid.org/0000-0003-2460-3036
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (P01HL053749)
U.S. Department of Health & Human Services | National Institutes of Health (R24DK106766, F32DK118822, P30CA21765)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM133614)
Article History
Received: 15 August 2020
Accepted: 25 June 2021
First Online: 2 August 2021
Competing interests
: M.J.W. is on advisory boards for Cellarity, Graphite Bio, Novartis and Forma Therapeutics, and is an equity owner of Beam Therapeutics. All other authors declare no competing interests.